Fcγ receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells

Blood

Volumn 120, Issue 26, 2012, Pages 5163-5172

  Flinsenberg, Thijs W H ^a   Compeer, Ewoud B ^a   Koning, Dan ^a   Klein, Mark ^a   Amelung, Femke J ^a   Van Baarle, Debbie ^a   Boelens, Jaap Jan ^a   Boes, Marianne ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DENDRITIC CELL VACCINE; FC RECEPTOR; GAMMA INTERFERON; HLA A2 ANTIGEN; TUMOR NECROSIS FACTOR; VIRUS ANTIGEN;

ARTICLE; BDCA 3+ CELL; BLOOD; CD8+ T LYMPHOCYTE; CELL CLONING; CROSS PRESENTATION; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL CULTURE; HUMAN CYTOMEGALOVIRUS; LYMPHOID TISSUE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS REACTIVATION;

EID: 84871499801     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-434498     Document Type: Article

References (48)

1. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357(25):2601- 2614,
2. Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood. 2009;113(23):5711-5719.
3. Flinsenberg TW, Compeer EB, Boelens JJ, Boes M. Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention. Clin Exp Immunol. 2011;165(1):8-18.
4. Compeer EB, Flinsenberg TW, van der Grein SG, Boes M. Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation. Front Immunol. 2012;3:37.
5. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449(7161):419- 426.
6. Heath WR, Carbone FR. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol. 2009;10(12):1237-1244.
7. Segura E, Villadangos JA. Antigen presentation by dendritic cells in vivo. Curr Opin Immunol. 2009;21(1):105-110.
8. Shortman K, Heath WR. The CD8+ dendritic cell subset. Immunol Rev. 2010;234(1):18-31.
9. Andersen BM, Ohlfest JR. Increasing the efficacy of tumor cell vaccines by enhancing cross priming. Cancer Lett. 2012;325(2):155-164.
10. Jongbloed SL, Kassianos AJ, McDonald KJ, et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med. 2010;207(6):1247-1260.
11. Poulin LF, Salio M, Griessinger E, et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med. 2010; 207(6):1261-1271.
12. Bachem A, Guttler S, Hartung E, et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med. 2010;207(6):1273-1281.
13. Schreibelt G, Klinkenberg LJ, Cruz LJ, et al. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-) presentation by human blood BDCA3+ myeloid dendritic cells. Blood. 2012; 119(10):2284-2292.
14. Bodeus M, Feyder S, Goubau P. Avidity of IgG antibodies distinguishes primary from nonprimary cytomegalovirus infection in pregnant women. Clin Diagn Virol. 1998;9(1):9-16. (Pubitemid 28153242)
15. Regnault A, Lankar D, Lacabanne V, et al. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med. 1999;189(2):371-380. (Pubitemid 29063258)
16. Rafiq K, Bergtold A, Clynes R. Immune complexmediated antigen presentation induces tumor immunity. J Clin Invest. 2002;110(1):71-79.
17. van Montfoort N, Mangsbo SM, Camps MG, et al. Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo. Eur J Immunol. 2012;42(3): 598-606.
18. Bolte S, Cordelieres FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224(Pt 3):213-232. (Pubitemid 46010930)
19. Liu Y, Gao X, Masuda E, Redecha PB, Blank MC, Pricop L. Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes. J Immunol. 2006; 177(12):8440-8447. (Pubitemid 44893806)
20. Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest. 2005;115(10):2914- 2923.
21. Fanger NA, Wardwell K, Shen L, Tedder TF, Guyre PM. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J Immunol. 1996; 157(2):541-548. (Pubitemid 26231354)
22. Gil-Torregrosa BC, Lennon-Dumenil AM, Kessler B, et al. Control of cross-presentation during dendritic cell maturation. Eur J Immunol. 2004;34(2):398-407. (Pubitemid 39255950)
23. Nagarajan S, Venkiteswaran K, Anderson M, Sayed U, Zhu C, Selvaraj P. Cell-specific, activation-dependent regulation of neutrophil CD32A ligand-binding function. Blood. 2000; 95(3):1069-1077. (Pubitemid 30062733)
24. Kim SH, Visser A, Cruijsen C, van der Velden AW, Boes M. Recruitment of Rab27a to phagosomes controls microbial antigen cross-presentation by dendritic cells. Infect Immun. 2008;76(11):5373- 5380.
25. Arrode G, Boccaccio C, Abastado JP, Davrinche C. Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells. J Virol. 2002;76(1):142- 150.
26. Vander Lugt B, Beck ZT, Fuhlbrigge RC, Hacohen N, Campbell JJ, Boes M. TGF-beta suppresses beta-catenin-dependent tolerogenic activation program in dendritic cells. PLoS One. 2011;6(5): e20099.
27. Jiang A, Bloom O, Ono S, et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity. 2007;27(4):610-624.
28. van Montfoort N, Camps MG, Khan S, et al. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc Natl Acad Sci U S A. 2009;106(16):6730-6735.
29. Segura E, Villadangos JA. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. Traffic. 2011;12(12): 1677-1685.
30. Ebstein F, Lehmann A, Kloetzel PM. The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation. Cell Mol Life Sci. 2012;69(14):2443-54.
31. Di Pucchio T, Chatterjee B, Smed-Sorensen A, et al. Direct proteasome-independent crosspresentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol. 2008;9(5):551-557. (Pubitemid 351560524)
32. Shen L, Sigal LJ, Boes M, Rock KL. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity. 2004;21(2):155-165. (Pubitemid 39094046)
33. Burgdorf S, Scholz C, Kautz A, Tampe R, Kurts C. Spatial and mechanistic separation of crosspresentation and endogenous antigen presentation. Nat Immunol. 2008;9(5):558-566. (Pubitemid 351560525)
34. Segura E, Valladeau-Guilemond J, Donnadieu MH, Sastre-Garau X, Soumelis V, Amigorena S. Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med. 2012; 209(4):653-660.
35. Crozat K, Guiton R, Contreras V, et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med. 2010;207(6):1283-1292.
36. Kovacsovics-Bankowski M, Rock KL.Aphagosome-to- cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 1995; 267(5195):243-246.
37. Houde M, Bertholet S, Gagnon E, et al. Phagosomes are competent organelles for antigen cross-presentation. Nature. 2003;425(6956):402- 406.
38. Ackerman AL, Kyritsis C, Tampe R, Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc Natl Acad Sci U S A. 2003;100(22):12889-12894. (Pubitemid 37339995)
39. Ackerman AL, Kyritsis C, Tampe R, Cresswell P. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat Immunol. 2005;6(1):107-113. (Pubitemid 40136702)
40. Cebrian I, Visentin G, Blanchard N, et al. Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell. 2011; 147(6):1355-1368.
41. Lizee G, Basha G, Tiong J, et al. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat Immunol. 2003;4(11):1065-1073. (Pubitemid 37428034)
42. Basha G, Lizee G, Reinicke AT, Seipp RP, Omilusik KD, Jefferies WA. MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells. PLoS One. 2008;3(9):e3247.
43. Basha G, Omilusik K, Chavez-Steenbock A, et al. A CD74-dependent MHC class I endolysosomal cross-presentation pathway. Nat Immunol. 2012; 13(3):237-245.
44. Wearsch PA, Cresswell P. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin- ERp57 heterodimer. Nat Immunol. 2007;8(8):873- 881.
45. Ackerman AL, Giodini A, Cresswell P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity. 2006;25(4):607-617. (Pubitemid 44529035)
46. Savina A, Jancic C, Hugues S, et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell. 2006;126(1):205-218. (Pubitemid 44026552)
47. Narbutt J, Lesiak A, Zak-Prelich M, et al. The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population. Cell Mol Biol Lett. 2004;9(3):497-509. (Pubitemid 39313075)
48. Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4: 3 markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165(11):6037-6046.